CLINICAL_TRIALS
trial_result
· 2015-06-11
Clinical Trial Update: Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus [Phase 1]
Summary
A Phase 1 safety and tolerability study of oral LGD-6972 in Type 2 Diabetes Mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ligand Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED